- Home
- ISPC vs PRFX Comparison
ISPC vs PRFX Comparison
Compare ISPC & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- PRFX
- Stock Information
- Founded
- ISPC 2009
- PRFX 2007
- Country
- ISPC United States
- PRFX Israel
- Employees
- ISPC N/A
- PRFX N/A
- Industry
- ISPC Precision Instruments
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- PRFX Health Care
- Exchange
- ISPC Nasdaq
- PRFX Nasdaq
- Market Cap
- ISPC 3.2M
- PRFX 3.6M
- IPO Year
- ISPC 2021
- PRFX 2020
- Fundamental
- Price
- ISPC $1.26
- PRFX $2.06
- Analyst Decision
- ISPC
- PRFX Hold
- Analyst Count
- ISPC 0
- PRFX 1
- Target Price
- ISPC N/A
- PRFX N/A
- AVG Volume (30 Days)
- ISPC 37.6K
- PRFX 55.9K
- Earning Date
- ISPC 08-05-2025
- PRFX 06-20-2025
- Dividend Yield
- ISPC N/A
- PRFX N/A
- EPS Growth
- ISPC N/A
- PRFX N/A
- EPS
- ISPC N/A
- PRFX N/A
- Revenue
- ISPC $8,058,631.00
- PRFX N/A
- Revenue This Year
- ISPC $35.93
- PRFX N/A
- Revenue Next Year
- ISPC N/A
- PRFX N/A
- P/E Ratio
- ISPC N/A
- PRFX N/A
- Revenue Growth
- ISPC N/A
- PRFX N/A
- 52 Week Low
- ISPC $1.02
- PRFX $1.68
- 52 Week High
- ISPC $11.80
- PRFX $18.17
- Technical
- Relative Strength Index (RSI)
- ISPC 55.51
- PRFX 51.59
- Support Level
- ISPC $1.15
- PRFX $1.93
- Resistance Level
- ISPC $1.29
- PRFX $2.11
- Average True Range (ATR)
- ISPC 0.08
- PRFX 0.10
- MACD
- ISPC 0.02
- PRFX 0.03
- Stochastic Oscillator
- ISPC 75.00
- PRFX 80.77
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.